Brief: Trinity Biotech PLC Files For Resale Of Up To 2.8 Mln ADSS By The Selling Shareholder
30/04/2024 22:50
April 30 (Reuters) - Trinity Biotech PLC TRIB.O :
* TRINITY BIOTECH PLC FILES FOR RESALE OF UP TO 2.8 MILLION
ADSS
BY THE SELLING SHAREHOLDER - SEC FILING
Source text for Eikon: ID:n0001178913-24-001492
Further company coverage: TRIB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trinity Biotech
See all newsNASDAQ RESUMED AT 12:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM